Documented concern based on cited evidence — not a personalized safety check, not medical advice, and not a decision to combine or avoid. That decision belongs with your prescriber.

Low-grade concern — timing, disclosure, or lab context

Low-grade documented concern. Timing, disclosure, or a lab context decides whether it matters for you.

Mechanism and evidence

Berberine inhibits CYP3A4 in vitro, the enzyme that clears ethinyl estradiol. The measured clinical anchor is transplant medicine (cyclosporine exposure up 34.5 percent); no contraceptive-specific human data exist. The concern is a plausible direction of changed exposure, not a measured effect.

Evidence tier: mechanistic

The tier names the strongest cited study design. Some anchors studied the supplement on its own, or a related drug in the same class — in those pairs the grade rests on that evidence plus established pharmacology, as agreed with our medical reviewer.

What to discuss with your prescriber

  • No measured effect of berberine on the pill exists; if you take both, a pharmacist conversation before stacking is the reasonable step.
  • If your prescriber approves berberine on top of a GLP-1 medication, bring the pill into the same conversation.

← All reviewed pairs for Oral contraceptives (combined pill)